Deputy Director, Office of Surveillance and Epidemiology, CDER, FDA, United States
Robert Ball MD, MPH, ScM is Deputy Director, Office of Surveillance and Epidemiology (OSE), Center for Drug Evaluation and Research (CDER), FDA. Dr. Ball shares in the responsibilities for leading OSE staff evaluating drug and biologic product safety and effectiveness using Real World...
Read More →
Vice President, Pharmacovigilance Excellence and International QPPV, AbbVie, Inc., United Kingdom
Qualified as a pharmacist in 1981 and started her career in hospital pharmacy. In 1983 she specialised in Drug Information Services and moved to Kuwait to set up and run the first National Drug Information Centre. On her return to the UK, Vicki spent the next four years in community...
Read More →
Head, International Pharmacovigilance. GCS&PV, Merck and Co., Inc., Denmark
Michelle is leading the International Pharmacovigilance organization at Merck. She has 25+ years of experience in the pharma industry and worked in clinical research and consulting prior to moving into pharmacovigilance (PV). Since joining Merck in 2002 she has performed various roles...
Read More →
Head QPPV PRRC Office, Chief Medical Office & Patient Safety, Novartis Pharma AG, Switzerland
Dr Dave Lewis joined Novartis in March 2007 following 20 years’ pharmacovigilance at GSK and at Shire. He has worked in country affiliates and in a variety of global safety & risk management functions with both investigational & marketed products, as well as in roles involving systems...
Read More →CZ
Associate Director for Medical Policy, Office of Biostatistics and Pharmacovigil, FDA, United States
Dr. Zinderman has worked in the Division of Epidemiology in the Office of Biostatistics and Pharmacovigilance (OBPV) since 2004. He initially served as a Medical Officer and Epidemiologist in the Therapeutics and Blood Safety Branch for 4 years, before becoming the Acting Branch Chief...
Read More → 
Create a custom schedule.
Take it with you on mobile.
Get listed in the directory.
